Italy vs Singapore: Life science patents granted, by filing office
Italy
0 patents
in 2023
Singapore
0 patents
in 2023
Italy rank
48th
Singapore rank
48th
Life science patents granted, by filing office over time
- Italy
- Singapore
How they compare
Italy currently reports 0 patents against 0 patents in Singapore, a difference of 0 patents.
The two have swapped places 7 times across 44 shared years of data; in 1980 it was Italy ahead.
Italy ranks 48th and Singapore ranks 48th of 70 countries.
Italy has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Italy | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 744.5 patents | 38.5 patents | 706 patents | Italy |
| 1990s | 492.6 patents | 53.2 patents | 439.4 patents | Italy |
| 2000s | 129.9 patents | 0 patents | 129.9 patents | Italy |
| 2010s | 44.2 patents | 0 patents | 44.2 patents | Italy |
| 2020s | 0 patents | 0 patents | 0 patents | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by filing office, Italy or Singapore?
- Italy, at 0 patents against 0 patents in Singapore as of 2023.
- What is the difference in life science patents granted, by filing office between Italy and Singapore?
- 0 patents, with Italy ahead.
- How many years of comparable data are there for Italy and Singapore?
- 44 years are reported by both, from 1980 to 2023.
- How do Italy and Singapore rank globally for life science patents granted, by filing office?
- Italy ranks 48th and Singapore ranks 48th of 70 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by filing office. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patents granted within the fields of medical technology, biotechnology, and pharmaceuticals by filing office. These patents cover a wide range of innovations, such as medical devices, diagnostic methods, genetic engineering techniques, biotechnological processes and new drugs.